John McAdory

Background

About John McAdory

John has spent the last 20 years global clinical research specializing in the development novel oncolytic therapies. He has lead global clinical operation from clinical study design to submission of final study report including BLA filing. John has expertise in strategy development, risk management, project planning and execution and consistently achieving program goals. With a Six Sigma Green Belt, John specializes in identifying key area to find efficiency in clinical study conduct to save time and reduce cost. John previously held leadership and management positions at SillaJen, Inc, Janssen, Inc, and Amgen. John is a graduate of Hampton University with an BS in biology and has a Masters in Health Administration from the University of North Carolina, Chapel Hill. Core Competencies•Expertise in all aspects of clinical operations project management.•Development of study plans and strategies including vendor management, communication, risk mitigation, trial budgets, recruitment and retention, and clinical supplies management•Designed and implemented relationship management strategies with clinical sites, external suppliers, and internal stakeholders.•Experience handling regulatory submission in North and South Americas, EMEA and APAC regions•Experience developing, building, and directing project teams •Experience monitoring in-patient and out-patient research studies. •Expert in ICH/GCP guidelinesExtensive therapeutic training in a broad range of diseases and treatments.